fold to an appropriate concentration (sp. gr. 1.01171.0157) and used as the culture medium for Lentinus edodes KSLE 007.10... The organism was cultured from a single spore isolate obtained at Gotemba, Shizuoka Pref., Japan. The organism was maintained on agar slants including the same culture medium.
Fermentation. A loopful of the L. edodes KSLE 007 maintained on a cultivation medium agar slant was transferred to 100 ml of sterile medium in a 200-m1 flask. After incubation on a reciprocating shaker for 10 days at 25°C, the contents of the flask were transferred aseptically to 500 ml of the sterile medium in a 1,000-mi Sakaguchi's flask and propagated in the same manner. The cultures were then transferred aseptically to 10 liters of the sterile medium (sp. gr. 1.015) in a jar fermenter and aerated at the rate of 10 liters of sterile air per minute for 10 days at 25°C.
Extraction and Purification Procedure.
Since the antitumor activity and the interferon-inducing activity in mice were observed to be parallel, 15 ' the active principle in the mycelial extract was pursued based on the interferon-inducing activity of the samples during the purification process. After 10 days of fermentation under the above conditions, the contents of the 10-liter jar fermenter were withdrawn and centrifuged at 3,000 rpm for 10 minutes. The mycelia obtained were homogenized in a Waring blender and subsequent extraction was carried out three times at about 90' 100°C with a total of 20 liters of boiling water. The hot water extracts were combined and mixed with three volumes of 96% ethanol and allowed to stand at 4°C overnight. The precipitates were collected by centrifugation and redissolved for lyophilization. The lyophilized powder (crude KS-2) was then dissolved in 50 ml of 0.01 M Tris-HCI buffer, pH 6.95 followed by overnight dialysis against the same buffer at 4°C. Then column chromatography with ECTEOLA-cellulose (5 cm x 70 cm) was performed.""" The column was eluted initially with 0.01 M Tris-HCI buffer, pH 6.95, then with 0.01 M Tris-HCI buffer containing a gradient of 0' 1.0 M NaCI, and finally with 0.5 M NaOH at 4°C at the flow rate of 1 ml/min. Ten ml aliquots of the effluent were collected in a fraction collector. Each effluent was monitored for total sugar content and absorption at 260 nm. The aliquots of each peak were combined, dialyzed against distilled water, lyophilized and analyzed for interferon-inducing activity. The lyophilized powder obtained from the first peak was then applied to a Sephadex G-100 column (5 cm x 60 cm) which was eluted with 0.3 M acetic acid containing 0.3 M NaCl.18' Each effluent was monitored for total sugar content, absorption at 260 nm and protein content. The aliquots of each peak were combined, dialyzed against distilled water, lyophilized and analyzed for interferon-inducing activity.`" Characterization of Chemical and Physical Properties.
(1) Ultracentrifugation: Density gradient centrifugation was performed with 3065% (w/w) CsCI in 0.1 M Tris HCI buffer, pH 7.2. Five mg of KS-2 and 4 ml of 48%. CsCI solution were mixed and centrifuged at 120,000g, at 4°C for 72 hours using a Hitachi RPS 50 ultracentrifuge.
After equilibrium was attained, a small pin-hole was punctured in the bottom of the centrifuge tube, and the effluent drops were analyzed for carbohydrate content by the phenol-H2SO4 method.
(2) Electrophoresis: Electrophoretic analyses were performed on cellulose acetate membranes (Separax) in 0.1 M acetic acid/pyridine buffer pH 6.95 at 0.3 mA/cm, 300 V. The carbohydrate content was monitored by the phenol-H2SO, method after extraction of 5-mm width cut-out pieces of cellulose acetate over the entire length of the strips.
(3) Molecular weight: The molecular weight of KS-2 was estimated by ultrafiltration using Amicon membrane filters PM-10, XM-50, and XM-100A (Amicon Inc., Lexington, Mass.). The membrane filter pore sizes permitted 50 % filtration of molecular weight of 104 (PM-10), 5'_ 104 (XM-50), and 105 (XM-100A) respectively. The standards used for the molecular weight estimation were: dextrans (DX-10, DX-40), dextran sulfate (DS-10, DS-500), and Ficoll (FC-400), all of which were products of Pharmacia Fine Chemical Inc., Stockholm, inulin (INU) and dextran (DX-75) which were obtained from Nutritional Biochem. Co., Cleveland, Ohio, via Wako Pure Chemical, Osaka, dextran sulfates (DS-3) which were a generous gift from Mcito Industries Co. Ltd., Nagoya, and purified chondroitin sulfate (CS-15) which was a generous gift from Dr. T. OKUYAMA, Seikagaku Kogyo Ltd., Tokyo. Their approximate molecular weights are shown in Fig. 6 . They were dissolved in either distilled water or 0.15 M NaCI in 0.01 M phosphate buffer (PBS), pH 7.2 at about 100 µg/ml or 200 µg/ml. About 5 ml of each was placed in an Amicon apparatus (Model MMC, 8 chambers) and 2.5 ml of filtrate were collected. The sugar contents before and after filtration (0.5 ml aliquot of the filtrates) were compared and expressed as % filtration.
(4) Susceptibility to a-mannosidase: a-Mannosidase (Seikagaku Kogyo Ltd., Lot ET 7101), obtained from marine gastropods (Turbo cornutus), is an unique exoglycosidase specific for a-linked mannose residues, liberating mannose from the nonreducing end."' KS-2 was treated with this enzyme in 0.2 M citrate/phosphate buffer (pH 4.0) containing 0.5 M NaCI. KS-2 or dextran (mol. wt. 7.5±1.5 x 104) at 5 mg/ml as the substrate was subjected to enzyme treatment. Ten milliunit of the enzyme/ml was used, and the reaction allowed to take place in a dialysis tube (about 1.0 cm x 4.5 cm) (8 x 100, Union Carbide Corp., Film and Packing Division, Chicago, I11.) which was placed in a test tube containing 30 ml of the above buffer. The reaction was carried out on a reciprocating shaker (120 Hz) at 26±2°C.
The sugar liberated from the dialysis tube into the buffer was quantitated by the phenol-H2SO, method at various time intervals and the susceptibility of the substrate to the enzyme was determined.
(5) Spectroscopical and optical properties: Infrared spectra were recorded using pellets composed of 2 mg of sample and 200 mg of KBr. Ultraviolet absorption spectra were recorded by a Hitachi Spectrophotometer Model 124 using 0.65%. KS-2, dissolved in PBS, pH 7.2.
[a];; was determined for an aqueous solution of the sample.
(6) Chemical Nature: Elemental analyses of the sample were performed routinely. The sugars in acid hydrolysates of the sample were estimated by a slight modification of SAWADECKER's method.20' A 3 mg sample was acid hydrolyzed with I N H2SO, at 100°C for 6 hours and reduced with NaBH4 at 25°C for 3 hours then acetylated with pyridine -acetic anhydride (1: 1) at 100°C for 2 hours. After the pyridine was removed in vacuo by rotary evaporation, the dried sample was dissolved in chloroform and applied to a column of 3 % ECNSS-M Gaschrom Q (mesh; 100 120) in a 0.3 cm x 2 m glass column attached to a Shimadzu model GC-5AP-5TF gas chromatographic analyzer equipped with a flame ionization detector. The amino acid composition of the sample was determined using a Hitachi KLA-3 amino acid autoanalyzer according to the method of MOORE and STEIN. 211 Eight mg of KS-2 was acid hydrolyzed with I .1 ml of 6 N HCI in vacuo at 110°C for 18 hours and then brought to dryness in vacuo.
Animals. DDI strain mice weighing 20-21 g were used for the experiments. They were obtained from the Central Farm of Tohoku University where care was taken to prevent infections with Sendai virus and mycoplasma.
Assay of Antitumor Activity.
(1) Tumors: EHRLICH carcinoma and Sarcoma-180 were used for testing the antitumor activity of KS-2 in vivo. Both were maintained continuously in our laboratory. 121 (2) Assay: For testing the antitumor activity of KS-2 against EHRLICH ascitic tumors, I x 106 or 5 x 103 tumor cells/mouse were inoculated intraperitoneally (i.p.) 24 hours before KS-2 administration. For testing the activity of KS-2 against solid tumors, about I x 106 Sarcoma-180 tumor cells obtained from ascites were inoculated intramuscularly (i.m.) into the thigh of the left back leg 24 hours before KS-2 administration.
The inoculum size of the tumor cells was specified in each experiment. KS-2 was dissolved in phosphate buffered saline (PBS) and was administered orally or intraperitoneally on a mg/kg basis 24 hours after tumor cell inoculation and once daily for 12 consecutive days. The evaluation of antitumor activity was based on the increase in mean survival days of mice over a 100 day (solid form tumor) or 50-day (ascitic form tumor) observation period and the increase in number of survivors on day 100 or day 50 with statistical evaluation by the STUDENT'S t test (mean survival days) and chi-square analysis (survivor number), respectively. If the p value obtained in each test was less than 0.05, the drug dose was considered statistically significant.
Assay of Interferon-Inducing Activity. A minor modification of LAMPSON'S method was employed to assay interferon induction in vivo.23) Briefly, mice were given KS-2 orally or intraperitoneally.
Sera were obtained from the treated mice at appropriate time intervals for antiviral assay. Assays for antiviral activity of mouse sera were carried out in L-1D cell cultures grown in EAGLE'S minimum essential medium (MEM) supplemented with 10% fetal calf serum at 37°C for 3 days. After overnight incubation with appropriately diluted serum specimens in the medium, the cells were washed with HANKS' balanced salt solution and challenged with 100 TCD50 of vesicular stomatitis virus (VSV). The reciprocal value of the maximal serum dilution which induced a definite inhibition of the viral cytopathic effect was taken as an interferon titer, which was converted to International Interferon Units using standard interferon from the National Institute of Health (Bethesda, Maryland).
Results

Fermentation
A typical time course of the fermentation in a 10-liter jar fermenter is shown in Fig. 1 . The mycelial weight increased gradually and reached a plateau after 10 days of fermentation. The total sugar content decreased and the pH fluctuated somewhat throughout fermentation.
Isolation and Purification After 10 days of fermentation under the above conditions, 2 kg (wet weight) of mycelia which was obtained from the contents of a 10-liter jar fermenter was subjected to hot water extraction and subsequently ethanol precipitation. Seven g of brownish amorphous powder designated as crude KS-2 was obtained. As shown in Table 1 , the crude KS-2 exhibited antitumor as well as interferoninducing activity. The crude KS-2 (4.0 g) was fractionated into three major peaks by ECTEOLAcellulose column chromatography (Fig. 2*) . The yields for peaks 1, 2 and 3 were 640, 138 and 115 mg respectively. The first peak (peak 1) gave a white amorphous powder with antitumor as well as interferon-inducing activity. The active fraction (peak 1) was rechromatographed on ECTEOLAand CM-cellulose columns for analytical purposes. Both gave a single and symmetrical peak.
Two hundred mg of the active fraction obtained from ECTEOLA-cellulose column chromatography was dissolved in 0.3 M acetic acid containing 0.3 M NaCI and further fractionated into three peaks by Sephadex G-100 column chromatography using the same acetic acid solution (Fig. 3) . The effluents from each peak were combined, dialyzed against distilled water and lyophilized. The first peak from the Sephadex G-100 column, called KS-2, gave 40 mg of white amorphous powder**. This fraction was rechromatographed on a Sephadex G-100 column for analytical purposes and confirmed the single and It was confirmed that KS-2's biological activities were not due to double-stranded RNA.
symmetrical moiety.
The biological activity at each step of the KS-2 purification is shown in Table   1 . The most purified fraction (peak 1 in Fig. 3 ), when administered orally at 20 mg/kg, induced 2,400 international units of interferon per ml of sera in mice about 20 hours after administration. Ten ml aliquots of the effluent were collected by a fraction collector and analyzed for total sugar at absorption of 490 nm and 260 nm.
Yields for peaks 1, 2 and 3 obtained from crude KS-2 were 640, 138 and 115 mg respectively.
Peaks 1, 2 and 3 had interferon inducing activities of 1,600, 200 and 200 respectively. 
Yields for peaks 1, 2 and 3 were 40, 15 and 8 mg respectively. The first peak had the interferoninducing activity of 2,400 international units. Interferon-inducing activity (Internat. unit/ml sera*) The relationships between the interferon-inducing activity and the dose level were found to be non. linear, thus no linear dose response was observed. In the present case, the optimum dose found wa! about 100 mg/kg for Peak 1** obtained from ECTEOLA-cellulose and 20 mg/kg for Peak 1*** obtained from Sephadex G-100 column. When this fraction was administered orally (100 mg/kg,,:13 successive days), the growth of Sarcoma-180 solid tumors was suppressed as well (Table 4) . However, the other 2 peaks in Fig. 3 did not show any appreciable antitumor activity.
Physical and Chemical Characterization of KS-2 In order to test the homogeneity of the KS-2, density gradient centrifugation with CsCI and electrophoretic analysis on cellulose acetate membranes were performed. As seen in Fig. 4 , the density gradient centrifugation of KS-2 exhibited a single and almost symmetrical peak. From this data, p was calculated to be 1.623. This KS-2 was considered to be centrifugally homogeneous. Fig. 5 shows KS-2 also exhibited a homogeneous character when it was subjected to electrophoresis. For an approximate estimation of the molecular weight of KS-2, an ultrafiltration experiment was performed. The averages of triplicate experiments were plotted as shown in Fig. 6 . The 50 filtration point was shown as an x mark for each membrane filter in order to estimate molecular weight. From these data, KS-2 appears to behave like a polysaccharide with an expected molecular weight between 6 and 9.5 x 10°.
The results of the amino acid analysis are shown in Table 2 . Antitumor Activities of KS-2
The antitumor activity of KS-2 was studied by the prolongation of the life span of mice bearing EHRLICH ascitic tumors. It was found that when 140 mg/kg of KS-2 was administered intraperitoneally, the survival of the mice inoculated with 5 x 103 cells/mouse of EHRLICH ascitic tumor increased during the experimental observation period for 50 days (Table 3) . Similar results were observed when KS-2 was administered orally to mice inoculated with EHRLICH ascitic tumor ( Table 3 ). The increase in survival rate of these mice was statistically significant. The increase in survival of mice inoculated with 1 x 106 cells/mouse of EHRLICH ascitic tumor was lower than those inoculated with 5 x 103 cells/mouse of the tumor cells (Table 3) . Thus the protective effects of KS-2 on ascitic tumors are considered to be dependent upon the inoculum size of the tumor cells. Although data are not shown (Table 5) .
Thus it was considered that KS-2 had no direct 
Discussion
As described above a new antitumor substance, KS-2, was prepared by propagating L. edodes KSLE 007 in medium containing thin stillage. KS-2 is a white amorphous powder, acting positively in the following chemical reactions: phenol-H2SO4, MoLtscH, anthrone, carbazole-H2S04, FOLINphenol, ninhydrin and biuret, but negatively in the ELSON-MORGAN reaction. KS-2 was shown to contain mannose as the major component and a small amount of peptide mainly composed of serine, threonine and alanine. Thus it is a peptide mannan. The purity of KS-2 was verified by CsCI density gradient centrifugation, cellulose acetate electrophoresis and rechromatography on ECTEOLAor DEAF-cellulose and Sephadex G-100 column chromatography.
The determination of polysaccharide molecular weights is a formidable task. Most of the polysaccharides and their peptide conjugates behave differently depending upon their structure and the conditions. Also, they exist in many cases as an average distribution of chain-lengths of similar but not identical sizes. They are not like proteins which possess a definite chemical structure and in which the molecular weights are explicit. The standard polysaccharides used in the present experiment for instance have a vast deviation in their molecular weights between number average molecular weight (Mn), and weight average molecular weight (Mw). For instance, DX--10 and DX 40 (both are Pharmacia preparations) possess average Mw of 9.4 x 103 and 4.1 >. 104 respectively, while their Mn are 5.5 >; 103 and 2.8 ;< 104 respectively. Therefore, the Mw values only were used as reference standards in the present work. They correlated, however, fairly well with the log of Mw and % of filtration for each membrane filter. As a result, the molecular weight of KS-2 was found to be 6.0-9.5 :< 104.
Digestion of KS-2 with a-mannosidase showed the presence of an a-linked configuration in KS-2. The relatively low rate of release of hexose (mannose) from KS-2 may indicate that either the enzyme action is blocked by the branched side chain in KS-2, i.e. the peptide component or the branching of the polysaccharide by a different configuration, or there is a limited number of nonreducing ends of mannose thus making much of it unavailable as the substrate. Chemical Studies of KS-2 such as acetolysis followed by the analysis of degradation products indicated the presence of a-linked mannose in KS-2 (a-1,3 and/or a-1,6: KATSUMATA, T., T. Funs and K. MATSUDA, unpublished data).
The several known high molecular weight antitumor substances, isolated from Basidiomycete fruithodies or the culture filtrates, such as lentinan," PSK" and shizophillan" appear to have some similarities to KS-2 in that they are polysaccharides and have the biological activity of inhibiting rodent tumors. It is reported, however, that lentinan is mainly composed of i3-1,3 glucan and has a molecular weight of about 1,000,000 but is devoid of peptide.21 PSK is reported to originate from Coriolus versicolor and to be mainly composed of 3-1,4 1,3-or jl-1,4 1,6 glucans and 10-15% peptide with a total estimated molecular weight of more than 94,000." Shizophillan is mainly composed of 8-1,3 1,6-glucans, with an estimated molecular weight of 10,000 80,000.31 Therefore, KS-2 is unique in its chemical nature because it is primarily a peptide containing a-mannan and has a definite molecular size.
In view of the biological characteristics of KS-2, the acute LD50 of KS-2 in mice was found to be 2,083 mg/kg after intraperitoneal injection and more than 12,500 mg/kg after oral administration, indicating an extremely low toxicity.l5,24 ' KS-2 did not show cytotoxic effects against the tumor cells tested but KS-2 when administered intraperitoneally as well as orally demonstrated an effective suppression of tumor growth at dose levels between I and 100 mg/kg. On the other hand, it was reported that neither lentinan nor shizophillan administered orally suppressed tumor growth.'12'3' Although PSK is reported to have an inhibitory effect against tumor growth when administered orally, the required dose (about 500 mg/kg)" seems to be much higher than that of KS-2. Thus, KS-2 appears again to be unique in its biological activity.
Similar polysaccharides have been derived from sources other than Basidiomycetes, e.g. a-mannan from yeast reported by KuMANO, MATSUDA et a/.2526' But the differences between the yeast mannan and KS-2 appear to be in the toxicity and the efficacy when dosed orally in experimental tumor-bearing animals. These comparative data indicate that KS-2 is in a novel class of antitumor substances.
The mechanism of action of KS-2 is not clear yet. But the result showed that KS-2 itself had no direct cytocidal effect against tumor cells in vitro. The antitumor activity by KS-2 was observed to be higher at the lower inoculum size of tumor cells, regardless of the routes of KS-2 administration (60% survival rate at 5 x 103 tumor cells/mouse, 10% survival at 1 x 106 tumor cells/mouse). The result showed that the antitumor activity of KS-2 found in mice was always accompanied by the induction of interferon in the sera. Furthermore our preliminary findings indicated that macrophage obtained from the KS-2 treated mice exhibited tumorcidal activity.27 SCHULTZ et al. reported that macrophage became tumorcidal when incubated in vitro with interferon.28' Considering these findings, the antitumor activity of KS-2 may be explained by the activation of macrophage with or without interferon induced by KS-2. However further investigation along this line should be required for the detailed elucidation of the mechanism of action.
In addition our recent preliminary findings indicated that KS-2 administered orally not only induced circulating interferon in mice and cured them from influenza infection, but also induced interferon in cancer patients, suggesting that KS-2 may exhibit a physiological activity in humans the details of which will be reported elsewhere. These findings strongly warrant further evaluation of KS-2.
